S&P 500

5.667,20

0,64%

Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.

Cadastre-se

HSP

Hospira (HSP)

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NYSE:HSP

<< Anterior 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
31/10/2011	11:45	Dow Jones News	Obama To Press FDA On Drug Shortages; Will Support Legislation	NYSE:HSP
26/10/2011	22:00	Zacks	Hospira, Inc. (HSP) - Bear of the Day	NYSE:HSP
26/10/2011	13:30	Zacks	Tough Quarter for Hospira - Analyst Blog	NYSE:HSP
26/10/2011	10:36	Edgar (US Regulatory)	Quarterly Report (10-Q)	NYSE:HSP
26/10/2011	10:16	Edgar (US Regulatory)	Current report filing (8-K)	NYSE:HSP
26/10/2011	09:33	PR Newswire (US)	Hospira Reports Third-Quarter 2011 Results	NYSE:HSP
21/10/2011	11:31	PR Newswire (US)	Critical Alerts For Nokia, NetApp, Hospira, Edwards Lifesciences, and Polycom Released By Seven Summits Research	NYSE:HSP
20/10/2011	11:00	Marketwired	Analyst View, Impact of Global Events - Research Report on Hospira, Inc. and DURECT Corporation	NYSE:HSP
19/10/2011	14:30	Zacks	Hospira Trims Outlook - Analyst Blog	NYSE:HSP
18/10/2011	17:13	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:HSP
18/10/2011	11:00	PR Newswire (US)	Hospira Announces Certain Preliminary Third-Quarter 2011 Results	NYSE:HSP
07/10/2011	17:15	Edgar (US Regulatory)	Amended Statement of Ownership (SC 13G/A)	NYSE:HSP
27/09/2011	15:20	PR Newswire (US)	Hospira to Host Conference Call for Third-Quarter 2011 Results	NYSE:HSP
23/09/2011	09:15	Dow Jones News	Cancer Drug Shortages Delay, Stop Work On Clinical Trials	NYSE:HSP
06/09/2011	13:36	PR Newswire (US)	Hospira Announces Positive Results From Phase I U.S. Clinical Trial of Biosimilar Erythropoietin in Renal Patients	NYSE:HSP
06/09/2011	08:30	PR Newswire (US)	DURECT Completes Enrollment in Pivotal U.S. Phase III Trial for POSIDUR® (BESST)	NYSE:HSP
01/09/2011	09:05	Marketwired	Equity Research on Alkermes Inc. and Hospira Inc. - Drug Delivery Sector's Relationship With the FDA	NYSE:HSP
29/08/2011	12:30	PR Newswire (US)	Hospira to Host 2011 Investor Day	NYSE:HSP
19/08/2011	14:14	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NYSE:HSP
18/08/2011	14:27	PR Newswire (US)	Hospira to Present at the Morgan Stanley Global Healthcare Conference	NYSE:HSP
17/08/2011	12:57	PR Newswire (US)	Hospira Expands Board of Directors	NYSE:HSP
15/08/2011	15:03	Zacks	Hospira Remains Neutral - Analyst Blog	NYSE:HSP
05/08/2011	15:01	Dow Jones News	Hospira To Offer Solution Form of Gemcitabine In September	NYSE:HSP
05/08/2011	12:32	PR Newswire (US)	Hospira Announces U.S. Approval of Solution Version of Gemcitabine Injection	NYSE:HSP
27/07/2011	09:48	Dow Jones News	Hospira 2Q Profit Surge 72% With Boost From Docetaxel Sales	NYSE:HSP
27/07/2011	08:32	PR Newswire (US)	Hospira Reports Second-Quarter 2011 Results	NYSE:HSP
27/07/2011	08:10	Zacks	Hospira Outshines Zacks Estimates - Analyst Blog	NYSE:HSP
26/07/2011	06:15	Zacks	Earnings Preview: Hospira - Analyst Blog	NYSE:HSP
12/07/2011	16:55	Dow Jones News	U.S. Hospitals Report Drug Shortages, Leading To Rationing	NYSE:HSP
30/06/2011	09:34	Marketwired	Research on Alkermes Inc. and Hospira Inc. - Drug Delivery Companies Looking for New Revenues	NYSE:HSP